Clinical Trial

To Evaluate the Safety, Tolerability and Pharmacokinetic of SAL0133 Tablets in Chinese Adult Healthy Subjects

Name: To Evaluate the Safety, Tolerability and Pharmacokinetic of SAL0133 Tablets in Chinese Adult Healthy Subjects — clinical trial record (NCT07030504)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

To evaluate the safety and tolerance of single and multiple administrations of SAL0133 tablets in adult healthy subjects in China receptivity.

Trial Details

NCT Number	NCT07030504
Lead Sponsor	Shenzhen Salubris Pharmaceuticals Co., Ltd.
Conditions	Pharmacokinetics
Enrollment	72 participants
Start Date	2023-01-10
Primary Completion	2025-06 (estimated)
Study Completion	2025-06 (estimated)
Updated on ClinicalTrials.gov	2025-06-22